[1]
Roy H, Nandi S. In-silico modeling in drug metabolism and interaction: current strategies of lead discovery. Curr Pharm Des 2019; 25(31): 3292-305.
[2]
Collery P, Desmaele D, Veena V. Design of rhenium compounds in targeted anticancer therapeutics. Curr Pharm Des 2019; 25(31): 3306-22.
[3]
Maushmi S Kumar, Yadav T, Khair R, Peters GJ, Mayur YC. Combination therapies of artemisinin and its derivatives as a viable approach for future cancer treatment. Curr Pharm Des 2019; 25(31): 3323-38.
[4]
Bera I, Payghan PV. Use of molecular dynamics simulations in structure-based drug discovery. Curr Pharm Des 2019; 25(31): 3339-49.
[5]
Tripathi P, Singh J, Lal JA, Tripathi V. Next generation sequencing: An emerging tool for drug designing. Curr Pharm Des 2019; 25(31): 3350-7.
[6]
Maurya NS, Kushwaha S, Mani A. Recent advances and computational approaches in peptide drug discovery. Curr Pharm Des 2019; 25(31): 3358-66.
[7]
Yadav BS, Chaturvedi N, Marina N. Recent advances in system based study for anti-malarial drug designing and development process. Curr Pharm Des 2019; 25(31): 3367-77.
[8]
Yadav TC, Agarwal V, Srivastava AK, et al. Insights into structure-function relationships of β-lactamase and BLIPs interface plasticity using protein-protein interactions. Curr Pharm Des 2019; 25(31): 3378-89.